Evidence map›Paper›PMID 34026461›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Engineered Matrices Enable the Culture of Human Patient-Derived Intestinal Organoids.

Daniel R Hunt, Katarina C Klett, Shamik Mascharak, Huiyuan Wang, Diana Gong, Junzhe Lou, Xingnan Li, Pamela C Cai, Riley A Suhar, Julia Y Co and 8 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Biomaterials in organoid research: current state and future directions.Frontiers in bioengineering and biotechnology · 2026
    Review
  15. Article
  16. Article
  17. Submucosal Hydrogel for Spring-Mediated Intestinal Lengthening.Journal of biomedical materials research. Part A · 2025
    Article
  18. Article
  19. Organoid bioprinting to pattern the matrix microenvironment.Current opinion in biomedical engineering · 2025
    Article
  20. Engineered Hydrogels for Organoid Models of Human Nonalcoholic Fatty Liver Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Daniel R HuntDepartment of Chemical Engineering Stanford University Stanford CA 94305 USA.
Katarina C KlettDepartment of Stem Cell Biology and Regenerative Medicine Stanford University Stanford CA 94305 USA.
Shamik MascharakDepartment of Bioengineering Stanford University Stanford CA 94305 USA.
Huiyuan WangDepartment of Materials Science & Engineering Stanford University Stanford CA 94305 USA.
Diana GongDepartment of Bioengineering Stanford University Stanford CA 94305 USA.
Junzhe LouDepartment of Chemistry Stanford University Stanford CA 94305 USA.
Xingnan LiDepartment of Medicine and Hematology Stanford University School of Medicine Stanford CA 94305 USA.
Pamela C CaiDepartment of Chemical Engineering Stanford University Stanford CA 94305 USA.
Riley A SuharDepartment of Materials Science & Engineering Stanford University Stanford CA 94305 USA.
Julia Y CoDepartment of Pediatrics (Infectious Diseases) and of Microbiology and Immunology Stanford University Stanford CA 94305 USA.
Bauer L LeSavageDepartment of Bioengineering Stanford University Stanford CA 94305 USA.
Abbygail A FosterDepartment of Materials Science & Engineering Stanford University Stanford CA 94305 USA.
Yuan GuanDepartment of Anesthesiology Stanford University School of Medicine Stanford CA 94305 USA.
Manuel R AmievaDepartment of Pediatrics (Infectious Diseases) and of Microbiology and Immunology Stanford University Stanford CA 94305 USA.
Gary PeltzDepartment of Anesthesiology Stanford University School of Medicine Stanford CA 94305 USA.
Yan XiaDepartment of Chemistry Stanford University Stanford CA 94305 USA.
Calvin J KuoDepartment of Medicine and Hematology Stanford University School of Medicine Stanford CA 94305 USA.
Sarah C HeilshornDepartment of Materials Science & Engineering Stanford University Stanford CA 94305 USA.ORCID 0000-0002-9801-6304

Funding

Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI AMIEVA, MANUEL R, KUO, CALVIN J · 2015 to 2025
$13.5M
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug AbuseU01DA044399 · NIDA · STANFORD UNIVERSITY · PI PELTZ, GARY A · 2017 to 2022
$4.7M
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and TherapyR01DK115728 · NIDDK · STANFORD UNIVERSITY · PI GARCIA, KENAN CHRISTOPHER, KUO, CALVIN J · 2018 to 2022
$3.9M
Graduate Training in Stem Cell Biology and Regenerative MedicineT32GM119995 · NIGMS · STANFORD UNIVERSITY · PI WEISSMAN, IRVING L. · 2017 to 2021
$2.0M
Stem Cell-Based In vivo Models of Human Genetic Liver DiseasesR01DK102182 · NIDDK · STANFORD UNIVERSITY · PI PELTZ, GARY A · 2015 to 2017
$1.7M
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cellsR01HL142718 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, HUANG, NGAN F. · 2018 to 2021
$1.6M
Engineered biomaterials to modulate cell-cell signaling for the robust expansion of stem cellsR01EB027171 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2019 to 2022
$1.4M
Engineered Protein Hydrogels to Modulate Adipose-derived Stromal Cell Secretome and Exosomes for Injectable Myocardial Infarction TherapyR21HL138042 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2017 to 2018
$435k
NHLBI NIH HHS R01 HL142718NHLBI NIH HHS R21 HL138042NIAID NIH HHS U19 AI116484NIBIB NIH HHS R01 EB027171NIDA NIH HHS U01 DA044399NIDDK NIH HHS R01 DK102182NIDDK NIH HHS R01 DK115728NIGMS NIH HHS T32 GM119995
6 · The paper itself

Abstract

Human intestinal organoids from primary human tissues have the potential to revolutionize personalized medicine and preclinical gastrointestinal disease models. A tunable, fully defined, designer matrix, termed hyaluronan elastin-like protein (HELP) is reported, which enables the formation, differentiation, and passaging of adult primary tissue-derived, epithelial-only intestinal organoids. HELP enables the encapsulation of dissociated patient-derived cells, which then undergo proliferation and formation of enteroids, spherical structures with polarized internal lumens. After 12 rounds of passaging, enteroid growth in HELP materials is found to be statistically similar to that in animal-derived matrices. HELP materials also support the differentiation of human enteroids into mature intestinal cell subtypes. HELP matrices allow stiffness, stress relaxation rate, and integrin-ligand concentration to be independently and quantitatively specified, enabling fundamental studies of organoid-matrix interactions and potential patient-specific optimization. Organoid formation in HELP materials is most robust in gels with stiffer moduli (

Indexed as

AnimalsCell DifferentiationCell SurvivalElastinEpithelial CellsExtracellular MatrixHumansHyaluronic AcidIntestinal MucosaMiceOrganoidsTissue EngineeringElastinHyaluronic Acid3D cell cultureadult stem cellsengineered biomaterialextracellular matrixintestinal organoid

Identifiers

PMID34026461
PMCPMC8132048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.